 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viveve Medical (NASDAQ:VIVE  Get Rating) was downgraded by research analysts at Alliance Global Partners from a buy rating to a neutral rating in a report released on Monday, The Fly reports. Viveve Medical Stock Performance Shares of NASDAQ VIVE opened at $0.10 on...

Viveve Medical (NASDAQ:VIVE) Stock Rating Lowered by Alliance Global Partners

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
The post Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on ...

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Study's primary efficacy endpoint was not achieved at 12 months post-treatmentCompany has implemented a reduction in forceCompany will seek strategic alternatives and will be delisted from Nasdaq ENGLEWOOD, CO / ACCESSWIRE / January 17, 2023 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical...

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial

Viveve Medical, Inc. (NASDAQ:VIVE  Get Rating) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 213,700 shares, a growth of 20.0% from the November 30th total of 178,100 shares. Based on an average daily volume of...

Short Interest in Viveve Medical, Inc. (NASDAQ:VIVE) Expands By 20.0%

Viveve Medical, Inc. (NASDAQ:VIVE  Get Rating) saw a significant increase in short interest in November. As of November 30th, there was short interest totalling 178,100 shares, an increase of 98.8% from the November 15th total of 89,600 shares. Based on an average daily volume of 22,900 ...

Viveve Medical, Inc. (NASDAQ:VIVE) Short Interest Update

Viveve Medical, Inc. (NASDAQ:VIVE  Get Rating) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 89,600 shares, a growth of 62.0% from the October 31st total of 55,300 shares. Based on an average ...

Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript

Total revenue of $1.7 million in Q3 including sale of 3,100 disposable treatment tipsPURSUIT clinical trial completion expected by year-endConference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / November 10, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical...

Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Viveve Medical Q3 2022 Earnings Preview

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered Englewood, CO.

Watchers	13,595
52-Wk Low	$0.0005
52-Wk High	$0.20

Market Cap	$18,200.00
Volume (M)	2,095.00
52-Wk High	$0.20
52-Wk Low	$0.0005

VIVE Viveve Medical Inc

About

Feed

News

Earnings

Fundamentals